# Graph AI

> AI-native pharmacovigilance platform (Graph Safety) that automates adverse-event intake and case processing for pharma and biotech.

## Why it is interesting

Insight-led $13.3M Series A on Sep 10, 2026 with Bessemer returning — company claims live deployments cut case turnaround from >3 hours to <10 minutes and operating costs up to 66%, turning services-heavy patient-safety ops into software.

## Profile

- **Latest funding:** Series A — $13.3M (September 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $13M
- **Stage:** series-a
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-09-11
- **Latest funding investors:** Insight Partners, Bessemer Venture Partners

## Key facts

- $13.3M Series A led by Insight Partners; Bessemer participated (Sep 10, 2026)
- Company: case TAT >3 hours → <10 minutes; opex down up to 66% in live deployments
- Seed October 2025; /report module launching September 2026

## Funding history

- Series A · $13.3M · September 2026
  Source: Https://www.prnewswire.com/news-releases/graph-ai-raises-13-3m-series-a-to-scale-the-first-ai-native-operating-system-for-patient-safety-302874459.html
- Seed · October 2025
  Source: Https://www.prnewswire.com/news-releases/graph-ai-raises-13-3m-series-a-to-scale-the-first-ai-native-operating-system-for-patient-safety-302874459.html

## Related articles

- https://venturecapitaltracker.com/2026-graph-ai-13-3m-series-a-insight-bessemer-patient-safety
- https://venturecapitaltracker.com/2026-september-10-11-investment-news-boring-positron-mach

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** September 11, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/graph-ai